Capula Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Sell |
850
-911
| -52% | -$169K | ﹤0.01% | 159 |
|
|
2025
Q1 | $369K | Buy |
1,761
+1,240
| +238% | +$260K | ﹤0.01% | 149 |
|
|
2024
Q4 | $92.6K | Buy |
521
+154
| +42% | +$27.4K | ﹤0.01% | 220 |
|
|
2024
Q3 | $72.5K | Buy |
367
+184
| +101% | +$36.3K | ﹤0.01% | 268 |
|
|
2024
Q2 | $31.4K | Sell |
183
-938
| -84% | -$161K | ﹤0.01% | 278 |
|
|
2024
Q1 | $204K | Buy |
+1,121
| New | +$204K | ﹤0.01% | 334 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 227 |
|
|
2023
Q3 | – | Sell |
-33,604
| Closed | -$4.53M | – | 313 |
|
|
2023
Q2 | $4.53M | Buy |
33,604
+31,906
| +1,879% | +$4.3M | 0.11% | 15 |
|
|
2023
Q1 | $271K | Buy |
+1,698
| New | +$271K | ﹤0.01% | 246 |
|
|
2022
Q4 | – | Sell |
-44,397
| Closed | -$5.96M | – | 424 |
|
|
2022
Q3 | $5.96M | Buy |
+44,397
| New | +$5.96M | 0.08% | 32 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 96 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 53 |
|
|
2021
Q4 | – | Sell |
-35,336
| Closed | -$3.77M | – | 38 |
|
|
2021
Q3 | $3.77M | Buy |
35,336
+26,173
| +286% | +$2.79M | 0.05% | 59 |
|
|
2021
Q2 | $1.02M | Buy |
9,163
+7,387
| +416% | +$824K | 0.02% | 80 |
|
|
2021
Q1 | $192K | Buy |
+1,776
| New | +$192K | ﹤0.01% | 131 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 76 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 32 |
|
|
2020
Q2 | – | Sell |
-92,257
| Closed | -$7.03M | – | 74 |
|
|
2020
Q1 | $7.03M | Buy |
92,257
+28,280
| +44% | +$2.15M | 0.25% | 24 |
|
|
2019
Q4 | $5.67M | Buy |
+63,977
| New | +$5.67M | 0.12% | 8 |
|
|
2019
Q3 | – | Sell |
-15,650
| Closed | -$1.14M | – | 61 |
|
|
2019
Q2 | $1.14M | Buy |
+15,650
| New | +$1.14M | 0.23% | 7 |
|